Equipment needed: Chest strap heart rate monitor (more accurate than wrist-based devices) Heart rate variability (HRV) app Blood pressure cuff Spreadsheet or tracking app Daily measurements: Morning resting heart rate (before getting up) Morning HRV (using chest strap, 5-minute measurement) Blood pressure (morning, before caffeine) What to track: 7-day rolling average of resting HR (smooths daily variation) HRV trend (declining HRV indicates autonomic stress) Blood pressure trend (should improve or stay stable) Subjective cardiac awareness (scale of 0-5) This level of monitoring is not necessary for most people, but for those who want complete data, it provides early warning of adverse trends and concrete evidence of cardiovascular adaptation over time
Key pathways, including Wnt/-catenin, bone morphogenetic protein 2/Smad, phosphoinositide 3-kinase/Akt and protein kinase A, play a role in this
adults reporting their use, according to a 2024 survey by KFF, a independent health policy research organization
The answers below are drawn from their research, cross-referenced against company filings, regulatory records, and clinical trial data
Medication adjustments might be necessary Sometimes, constipation can be severe enough to warrant adjusting your Ozempic treatment: Slower dose escalation may help staying longer at a lower dose before increasing can give your body more time to adapt Temporary dose reduction might be considered for significant constipation that doesn't respond to other measures Constipation itself usually isnt reason enough to stop Ozempic treatment altogether
About Wegovy 1 Health Canada approved Wegovy in 2021 as a once-weekly treatment for Canadians living with obesity, supported by the efficacy and safety data from the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program